A man with recurrent hypovolemic shock on anti-programmed cell death protein 1 treatment: Immune-related protein-losing enteropathy

被引：3
|
作者：
Lee, Seo Young [1 ]
Kim, Min Hwan [1 ]
Jang, Mi [2 ]
Park, Yehyun [3 ]
Cho, Byoung Chul [1 ]
机构：
[1] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Div Med Oncol,Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Dept Internal Med, Inst Gastroenterol, Seoul, South Korea
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 104卷
关键词：
D O I：
10.1016/j.ejca.2018.09.015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：104 / 107
页数：4
相关论文
共 50 条
  • [31] Association of Anti-Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic Melanoma
    Brunot, Angelique
    Grob, Jean-Jacques
    Jeudy, Geraldine
    Grange, Florent
    Guillot, Bernard
    Kramkimel, Nora
    Mortier, Laurent
    Le Corre, Yannick
    Aubin, Francois F.
    Mansard, Sandrine
    Lebbe, Celeste
    Blom, Astrid
    Montaudie, Henri
    Giacchero, Damien
    Prey, Sorilla
    Legoupil, Delphine
    Guyot, Alexis
    Amini-adle, Mona
    Granel-Brocard, Florence
    Meyer, Nicolas
    Dinulescu, Monica
    Edeline, Julien
    Campillo-Gimenez, Boris
    Lesimple, Thierry
    JAMA DERMATOLOGY, 2020, 156 (09) : 982 - 986
  • [32] Clinically applicable cases of anti-programmed cell death protein 1 immunotherapy for colorectal cancer patients
    Chikatani, Kenichi
    Chika, Noriyasu
    Suzuki, Okihide
    Sakimoto, Takehiko
    Ishibashi, Keiichiro
    Eguchi, Hidetaka
    Okazaki, Yasushi
    Ishida, Hideyuki
    SURGERY TODAY, 2020, 50 (12) : 1694 - 1698
  • [33] Impact of aging on immune-related adverse events generated by anti-programmed death (ligand)PD-(L)1 therapies
    Baldini, Capucine
    Romano, Patricia Martin
    Voisin, Anne-Laure
    Danlos, Francois-Xavier
    Champiat, Stephane
    Laghouati, Salim
    Kfoury, Maria
    Vincent, Helene
    Postel-Vinay, Sophie
    Varga, Andreea
    Vuagnat, Perrine
    Ribrag, Vincent
    Mezquita, Laura
    Besse, Benjamin
    Hollebecque, Antoine
    Lambotte, Olivier
    Michot, Jean-Marie
    Soria, Jean-Charles
    Massard, Christophe
    Marabelle, Aurelien
    EUROPEAN JOURNAL OF CANCER, 2020, 129 : 71 - 79
  • [34] Three cases of immune cholangitis related to anti-programmed cell death and programmed cell death ligand agents for the treatment of non-small cell lung cancer
    Fouchard, Maxime
    Jantzem, Helene
    Quere, Gilles
    Descourt, Renaud
    Robinet, Gilles
    Poureau, Pierre-Guillaume
    EUROPEAN JOURNAL OF CANCER, 2019, 115 : 107 - 110
  • [35] Unfolding the potential of anti-programmed cell death protein 1 blockade in Hodgkin lymphoma - combination and personalisation?
    Brockelmann, Paul J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (01) : 10 - 12
  • [36] Local Recurrent Melanoma Treated with BRAF and MEK Inhibitors Despite Adjuvant Anti-Programmed Cell Death Protein 1 Antibody Therapy
    Hwang, Hye Won
    Lee, Seon Bok
    Shin, Hyun-Tae
    Shin, Jeonghyun
    Choi, Gwang Seong
    Byun, Ji Won
    ANNALS OF DERMATOLOGY, 2023, 35 : S373 - S375
  • [37] Recurrent Pneumonitis Induced by Atezolizumab (Anti-Programmed Death Ligand 1) in NSCLC Patients Who Previously Experienced Anti-Programmed Death 1 Immunotherapy-Related Pneumonitis
    Hsu, Ping-Chih
    Li, Shih-Hong
    Yang, Cheng-Ta
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (11) : E227 - E230
  • [38] New insights into programmed cell death protein 1 blockade-associated cutaneous immune-related adverse events
    Micevic, Goran
    Daniels, Andrew
    Flavell, Richard A.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (04) : 355 - 357
  • [39] Clinically applicable cases of anti-programmed cell death protein 1 immunotherapy for colorectal cancer patients
    Kenichi Chikatani
    Noriyasu Chika
    Okihide Suzuki
    Takehiko Sakimoto
    Keiichiro Ishibashi
    Hidetaka Eguchi
    Yasushi Okazaki
    Hideyuki Ishida
    Surgery Today, 2020, 50 : 1694 - 1698
  • [40] Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy
    Blair, Alex B.
    Wang, Jianxin
    Davelaar, John
    Baker, Andrew
    Li, Keyu
    Niu, Nan
    Wang, Junke
    Shao, Yingkuan
    Funes, Vanessa
    Li, Pan
    Pachter, Jonathan A.
    Maneval, Daniel C.
    Dezem, Felipe
    Plummer, Jasmine
    Chan, Keith Syson
    Gong, Jun
    Hendifar, Andrew E.
    Pandol, Stephen J.
    Burkhart, Richard
    Zhang, Yuqing
    Zheng, Lei
    Osipov, Arsen
    GASTROENTEROLOGY, 2022, 163 (05) : 1267 - +
12345